Consensus Cross Country Healthcare, Inc.

Equities

CCRN

US2274831047

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
14.49 ^USD	-0.55%		-3.85%	-36.00%

May. 06	Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating	MT
May. 01	(CCRN) CROSS COUNTRY HEALTHCARE Sees Q2 EPS Range $0.10 - $0.20	MT

Evolution of the average Target Price on Cross Country Healthcare, Inc.

Price target over the last 5 years

History of analyst recommendation changes

226660054018f5f95eb0b.VF-6ng7pUkSxIrcg3Lbq_v3yaI-yrTAu_uB3Do8jbf0.CwXZ1mejFDTjR-9YktvbhMqQRcKDnF5nro8yX-pgX89lDNndVocRD9997g~ad8786fdc81eba81832dd25d220ef13b

Analyst Recommendations on Cross Country Healthcare, Inc.

Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating	May. 06	MT
Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating	Feb. 27	MT
UBS Adjusts Cross Country Healthcare Price Target to $19 From $22, Maintains Neutral Rating	Feb. 23	MT
Truist Adjusts Cross Country Healthcare's Price Target to $16 From $22, Keeps Hold Rating	Feb. 22	MT
JMP Securities Initiates Cross Country Healthcare With Market Perform Rating	Dec. 06	MT
UBS Initiates Coverage on Cross Country Healthcare With Neutral Rating, $22 Price Target	Nov. 30	MT
Barrington Cuts Price Target on Cross Country Healthcare to $26 From $29, Keeps Outperform Rating	Nov. 29	MT
Jefferies Downgrades Cross Country Healthcare to Hold From Buy, Adjusts Price Target to $21 From $32	Nov. 03	MT
Barrington Cuts Price Target on Cross Country Healthcare to $29 From $35 Amid Reduction in Estimates, Keeps at Outperform	23-08-14	MT
Credit Suisse Adjusts Cross Country Healthcare's Price Target to $26 From $27, Keeps Neutral Rating	23-08-08	MT
William Blair Initiates Cross Country Healthcare at Outperform Rating	23-06-26	MT
Barrington Research Cuts Cross Country Healthcare's Price Target to $35 From $42, Maintains Outperform Rating	23-05-31	MT
Credit Suisse Lowers Cross Country Healthcare's Price Target to $27 From $32, Keeps Neutral Rating	23-05-05	MT
Truist Securities Adjusts Cross Country Healthcare Price Target to $25 From $38, Maintains Hold Rating	23-05-02	MT
Loop Capital Initiates Cross Country Healthcare at Buy Rating With $30 Price Target	23-03-10	MT
Barrington Trims Price Target on Cross Country Healthcare to $42 From $45, Reiterates Outperform Rating	23-03-01	MT
Benchmark Capital Adjusts Cross Country Healthcare Price Target to $40 From $45, Maintains Buy Rating	23-02-23	MT
Credit Suisse Lifts Cross Country Healthcare's Price Target to $32 From $31 After Higher-Than-Expected Q4 Results, Keeps Neutral Rating	23-02-23	MT
Barrington Raises Price Target on Cross Country Healthcare to $45 From $41, Affirms Outperform Rating	22-11-07	MT
Truist Securities Downgrades Cross Country Healthcare to Hold From Buy; Price Target is $36	22-10-05	MT
Barrington Research Raises Price Target for Cross Country Healthcare to $41 From $40, Maintains Outperform Rating	22-09-15	MT
Benchmark Adjusts Price Target on Cross Country Healthcare to $42 From $37, Reiterates Buy Rating	22-09-15	MT
Barrington Research Lowers Price Target for Cross Country Healthcare to $40 From $44, Maintains Outperform Rating	22-08-19	MT
Benchmark Adjusts Price Target on Cross Country Healthcare to $37 From $42, Reiterates Buy Rating	22-06-13	MT
Credit Suisse Adjusts Cross Country Healthcare's PT to $26 from $28, Says Current Market Conditions Hurting Valuations Across Board; Keeps Neutral Rating	22-06-09	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

14.57 USD

Average target price

18.17 USD

Spread / Average Target

+24.69%

High Price Target

21 USD

Spread / Highest target

+44.13%

Low Price Target

16 USD

Spread / Lowest Target

+9.81%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cross Country Healthcare, Inc.

Barrington Research
UBS
Truist Securities
JMP Securities
Jefferies & Co.
Credit Suisse
William Blair & Co.
Loop Capital
Benchmark Company
Benchmark Capital
BofA Securities

Ratings for Cross Country Healthcare, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar